Biotech Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets May 3, 2024
Biotech Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors April 24, 2024
Biotech Outrun Therapeutics launches with a $10m seed financing from M Ventures and MP Healthcare Venture Management to develop a protein stabilisation pipeline April 18, 2024
Biotech SK chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear April 18, 2024